121 related articles for article (PubMed ID: 16914927)
1. Influence of relatives on fatigue experienced by patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I.
Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
Eur Neurol; 2006; 56(1):24-30. PubMed ID: 16914927
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.
Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
Acta Neurol Scand; 2007 Apr; 115(4):265-70. PubMed ID: 17376125
[TBL] [Abstract][Full Text] [Related]
3. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
J Psychosom Res; 2007 May; 62(5):571-9. PubMed ID: 17467412
[TBL] [Abstract][Full Text] [Related]
4. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.
Kalkman JS; Schillings ML; van der Werf SP; Padberg GW; Zwarts MJ; van Engelen BG; Bleijenberg G
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1406-9. PubMed ID: 16170086
[TBL] [Abstract][Full Text] [Related]
5. Experienced and physiological fatigue in neuromuscular disorders.
Schillings ML; Kalkman JS; Janssen HM; van Engelen BG; Bleijenberg G; Zwarts MJ
Clin Neurophysiol; 2007 Feb; 118(2):292-300. PubMed ID: 17166763
[TBL] [Abstract][Full Text] [Related]
6. Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.
Kalkman JS; Zwarts MJ; Schillings ML; van Engelen BG; Bleijenberg G
Neurol Sci; 2008 Sep; 29 Suppl 2():S238-40. PubMed ID: 18690504
[TBL] [Abstract][Full Text] [Related]
7. Employment status of patients with neuromuscular diseases in relation to personal factors, fatigue and health status: a secondary analysis.
Minis MA; Kalkman JS; Akkermans RP; Engels JA; Huijbregts PA; Bleijenberg G; Oostendorp RA; van Engelen BG
J Rehabil Med; 2010 Jan; 42(1):60-5. PubMed ID: 20111846
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and correlates of apathy in myotonic dystrophy type 1.
Gallais B; Montreuil M; Gargiulo M; Eymard B; Gagnon C; Laberge L
BMC Neurol; 2015 Aug; 15():148. PubMed ID: 26296336
[TBL] [Abstract][Full Text] [Related]
9. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
[TBL] [Abstract][Full Text] [Related]
10. Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire.
Vandervelde L; Van den Bergh PY; Goemans N; Thonnard JL
Neuromuscul Disord; 2009 Feb; 19(2):99-103. PubMed ID: 19167889
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
12. Fatigue in facioscapulohumeral muscular dystrophy: a qualitative study of people's experiences.
Schipper K; Bakker M; Abma T
Disabil Rehabil; 2017 Sep; 39(18):1840-1846. PubMed ID: 27762634
[TBL] [Abstract][Full Text] [Related]
13. Fatigue and neuromuscular diseases.
Féasson L; Camdessanché JP; El Mandhi L; Calmels P; Millet GY
Ann Readapt Med Phys; 2006 Jul; 49(6):289-300, 375-84. PubMed ID: 16780988
[TBL] [Abstract][Full Text] [Related]
14. Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD: an RCT.
Voet N; Bleijenberg G; Hendriks J; de Groot I; Padberg G; van Engelen B; Geurts A
Neurology; 2014 Nov; 83(21):1914-22. PubMed ID: 25339206
[TBL] [Abstract][Full Text] [Related]
15. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy.
van der Kooi EL; Kalkman JS; Lindeman E; Hendriks JC; van Engelen BG; Bleijenberg G; Padberg GW
J Neurol; 2007 Jul; 254(7):931-40. PubMed ID: 17361345
[TBL] [Abstract][Full Text] [Related]
16. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).
Hilbert JE; Kissel JT; Luebbe EA; Martens WB; McDermott MP; Sanders DB; Tawil R; Thornton CA; Moxley RT;
Contemp Clin Trials; 2012 Mar; 33(2):302-11. PubMed ID: 22155025
[TBL] [Abstract][Full Text] [Related]
17. Differences in respiratory function, depressive symptoms and quality of life between patients with hereditary motor and sensory neuropathy and myotonic dystrophy undergoing maintenance rehabilitation.
Lajlar N; Vidmar G; Moharić M
Int J Rehabil Res; 2024 Mar; 47(1):20-25. PubMed ID: 38096027
[TBL] [Abstract][Full Text] [Related]
18. Experiences with bariatric surgery in patients with facioscapulohumeral dystrophy and myotonic dystrophy type 1: A qualitative study.
Abel EEDH; Cup EHC; Lanser A; Leclercq WKG; Raaphorst J; Padberg GW; Satink T; Voermans NC
Neuromuscul Disord; 2018 Nov; 28(11):938-946. PubMed ID: 30342904
[TBL] [Abstract][Full Text] [Related]
19. Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.
Carter GT; Han JJ; Mayadev A; Weiss MD
Am J Hosp Palliat Care; 2006; 23(5):412-6. PubMed ID: 17060310
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular electrical stimulation training: a safe and effective treatment for facioscapulohumeral muscular dystrophy patients.
Colson SS; Benchortane M; Tanant V; Faghan JP; Fournier-Mehouas M; Benaïm C; Desnuelle C; Sacconi S
Arch Phys Med Rehabil; 2010 May; 91(5):697-702. PubMed ID: 20434605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
